RT @Oncotarget: #PaperoftheDay: "ACSL4: biomarker, mediator and target in quadruple negative breast cancer" DOI: https://t.co/qn6Ns6ixQ4 #…
#PaperoftheDay: "ACSL4: biomarker, mediator and target in quadruple negative breast cancer" DOI: https://t.co/qn6Ns6ixQ4 #cancerresearch #oncology #OA #MedEd
乳がん分類の新たなバイオマーカー ACSL4って酵素をバイオマーカーとして乳がんの各サブタイプへの治療レジメンに対する反応予測因子として利用できるのでは?みたいなデータをレビューしてる総説 乳がんのサブタイプをしっかり分類するのは大事だもんねぇ https://t.co/Uqp6NKhTLP
RT @physorg_health: #ACSL4: Biomarker, mediator and target in quadruple negative breast #cancer @OncotargetJrnl https://t.co/HM1akJBTgf htt…
#ACSL4: Biomarker, mediator and target in quadruple negative breast #cancer @OncotargetJrnl https://t.co/HM1akJBTgf https://t.co/UHieSJnEpE
#TrendingWithImpact: On June 12, 2023, researcher Marie E. Monaco from @nyugrossman and @VANYHarbor published a new review paper in Oncotarget, entitled, “ACSL4: biomarker, mediator and target in quadruple negative breast cancer.” DOI: https://t.co/qn6Ns6
NEW #PaperoftheDay: "ACSL4: biomarker, mediator and target in quadruple negative breast cancer" https://t.co/qn6Ns6i00w #cancerresearch #oncology #openaccess #peerreviewed #OA